538 related articles for article (PubMed ID: 8640712)
21. Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia.
Rasul I; Shepherd FA; Kamel-Reid S; Krajden M; Pantalony D; Heathcote EJ
Hepatology; 1999 Feb; 29(2):543-7. PubMed ID: 9918933
[TBL] [Abstract][Full Text] [Related]
22. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
Davis GL; Lau JY
J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
[TBL] [Abstract][Full Text] [Related]
23. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
[TBL] [Abstract][Full Text] [Related]
24. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.
Vallat L; Benhamou Y; Gutierrez M; Ghillani P; Hercher C; Thibault V; Charlotte F; Piette JC; Poynard T; Merle-Béral H; Davi F; Cacoub P
Arthritis Rheum; 2004 Nov; 50(11):3668-78. PubMed ID: 15529359
[TBL] [Abstract][Full Text] [Related]
25. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia.
Sinico RA; Ribero ML; Fornasieri A; Renoldi P; Zhou J; Fasola M; Portera G; Arrigo G; Gibelli A; D'Amico G
QJM; 1995 Nov; 88(11):805-10. PubMed ID: 8542265
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
28. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
Hige S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
[TBL] [Abstract][Full Text] [Related]
30. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
[TBL] [Abstract][Full Text] [Related]
31. Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers.
Magalini AR; Facchetti F; Salvi L; Fontana L; Puoti M; Scarpa A
J Pathol; 1998 May; 185(1):86-90. PubMed ID: 9713364
[TBL] [Abstract][Full Text] [Related]
32. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
[TBL] [Abstract][Full Text] [Related]
33. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
[TBL] [Abstract][Full Text] [Related]
34. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
35. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
De Re V; De Vita S; Sansonno D; Gasparotto D; Simula MP; Tucci FA; Marzotto A; Fabris M; Gloghini A; Carbone A; Dammacco F; Boiocchi M
Rheumatology (Oxford); 2006 Jun; 45(6):685-93. PubMed ID: 16399842
[TBL] [Abstract][Full Text] [Related]
36. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia.
Sansonno D; Cornacchiulo V; Iacobelli AR; Di Stefano R; Lospalluti M; Dammacco F
Hepatology; 1995 Feb; 21(2):305-12. PubMed ID: 7843698
[TBL] [Abstract][Full Text] [Related]
37. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.
Hayashi J; Ohmiya M; Kishihara Y; Tani Y; Kinukawa N; Ikematsu H; Kashiwagi S
Am J Gastroenterol; 1994 Dec; 89(12):2151-6. PubMed ID: 7977232
[TBL] [Abstract][Full Text] [Related]
38. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection.
King PD; McMurray RW; Becherer PR
Am J Gastroenterol; 1994 Jul; 89(7):1047-50. PubMed ID: 7517099
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
40. Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon.
Picciotto A; Icardi G; Bardellini E; Borro P; Borzone S; Pireddu M; Sinelli N; Pezzano D; Orione L; Di Giacomo C
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):623-5. PubMed ID: 8590156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
